Merck Acquires Much Needed Diversification With $10.8bn Prometheus Buy

$200 Per Share Buyout Is 75% Premium

 
• By Mandy Jackson
Pain in human intestines, bowel concept
PRA023 will move into Phase III in ulcerative colitis and Crohn's disease in late 2023 or early 2024 • Source: Shutterstock

More from Deals

More from Business